Continuous Glucose Monitoring in Patients Undergoing Extracorporeal Ventricular Assist Therapy.

ABSTRACT:

Background

Dysregulations of blood glucose (BG) are associated with adverse outcome in critical illness; controlling BG to target appears to improve outcome. Since BG-control is challenging in daily intensive care practice BG-control remains poor especially in patients with rapidly fluctuating BG. To improve BG-control and to avoid deleterious hypoglycemia, automated online-measurement tools are advocated. We thus evaluated the point-accuracy of the subcutaneous Sentrino® Continuous Glucose Monitoring System (CGM, Medtronic Diabetes, Northridge, California) in patients undergoing extracorporeal cardiac life support (ECLS) for cardiogenic shock.

Methods

Management of BG was performed according to institute's standard aiming at BG-levels between 100-145 mg/dl. CGM-values were

SUBMITTER: Gottschalk A 

PROVIDER: S-EPMC4786282 | biostudies-literature | 2016

REPOSITORIES: biostudies-literature